MEDICAL SERVICES' NET INCOME INCREASES 208% FOR
YEAR.(Medical Services International Inc)(Brief Article)(Statistical
Data Includ
Medical Services International Inc., Edmonton, Alberta, (Pink
Sheets:MSITF) has announced its financial results for the year ending
June 30, 2001.
Total revenue increased by 41% from $954,859 . . .
VALLEY FORGE REPORTS GAINS IN 4TH QTR/YEAR-END RESULTS.(Valley
Forge Scientific Corp)(Brief Article)(Statistical Data Included)
Valley Forge Scientific Corp. (NASDAQ: VLFG; BSE: VLF), Oaks, Pa.,
which develops and manufactures medical device products for hospital and
healthcare markets worldwide, today reported results for . . .
BIOMET REPORTS RECORD SECOND QUARTER RESULTS.(company financial
reporting data)(Brief Article)(Statistical Data Included)
Biomet, Inc. (Nasdaq:BMET), Warsaw, Ind., has reported record
sales and earnings results for its second quarter ended November 30,
2001. Net sales increased 18% to $289,387,000. Operating . . .
VIDAMED REPORTS 4TH QTR INCREASED REVENUES/PROCEDURES.(VidaMed
Inc)(Brief Article)(Statistical Data Included)
VidaMed, Inc. (Nasdaq:VIDA), Fremont, Calif., has reported record
revenues and TUNA (Transurethral Needle Ablation) system procedures, for
the treatment of BPH (Benign Prostatic Hyperplasia, or . . .
BRITISH BIOTECH'S SIX-MONTH LOSS DECREASED TO
US$12.2M.(Statistical Data Included)
British Biotech (LSE:BBG)(Nasdaq:BBIOY), Oxford, England, has
announced its interim results for the six months ended October 31, 2001.
Highlights of the period include the following:
-- Patient . . .
NOVAMETRIX REPORTS 2ND QTR NET INCOME INCREASES 28%.(Novametrix
Medical Systems Inc.)(Brief Article)
Reflecting the company's focus on increasing sales of
cardiopulmonary products, which contributed to higher gross margins, as
well as its initiatives to improve operations, which contributed . . .
AMGEN EXPECTS ACCELERATED GROWTH IN 2002 FINANCIAL RESULTS.(Brief
Article)
Amgen (Nasdaq:AMGN), Thousand Oakes, Calif., expects earnings per
share will significantly accelerate in 2002 driven by product sales
growth.
For 2002, Amgen expects earnings per share to grow . . .
IMMUNE NETWORK REPORTS 9-MONTH NET LOSS OF NEARLY $9
MILLION.(Brief Article)
Immune Network Ltd. (OTC: IMMKF; CDNX: IMM), Vancouver, BC, has
announced third quarter results, changes in management and the board,
and the anniversary of its Alzheimer clinical trial . . .
DENDRITE REPORTS STRONG 3RD QUARTER RESULTS.(Brief
Article)(Statistical Data Included)
Dendrite (NASDAQ/NMS: DRTE), Morristown, N.J., an innovator in
global pharmaceutical technology, has announced strong third quarter
results, beating analyst revenue and EPS expectations.
Revenue . . .
SEATTLE GENETICS REPORTS INCREASED 3RD QTR REVENUES.(Brief
Article)(Statistical Data Included)
Seattle Genetics, Inc. (Nasdaq:SGEN), Bothell, Wash., has reported
results for its third quarter and nine months ended September 30, 2001.
Revenues for the quarter were $70,000, compared to . . .
CEPHEID REPORTS $2.8 MILLION 3RD QTR. REVENUES.(Brief
Article)(Statistical Data Included)
Cepheid (Nasdaq: CPHD), Sunnyvale, Calif., developers and
marketers of rapid, on-site DNA detection systems, has announced
financial results for the quarter and nine months ended September . . .
CERUS REPORTS THIRD QUARTER NET LOSS OF $12.7 MILLION.(Brief
Article)(Statistical Data Included)
Cerus Corporation (Nasdaq:CERS), Concord, Calif., has announced
results for the third quarter ended September 30, 2001.
The net loss for the third quarter was $12.7 million, or $0.81 per
share, . . .
AGENIX FIRST QUARTER REVENUE UP 55%.(Brief Article)(Statistical
Data Included)
Agenix Limited [ASX:AGX] has announced a 55% increase in
first-quarter revenue to $7.6 million. The revenue for the corresponding
period last year was $4.9 million.
Revenue from human and . . .
AKZO NOBEL'S PHARMA ON COURSE FOR DOUBLE-DIGIT
GROWTH.(financial outlook and management strategies for Pharma Group and
other Ak
Akzo Nobel's recently restructured Pharma Group is primed to
deliver double-digit growth this year on a business-like basis.
The restructuring has strengthened the Group's strategic focus
on . . .
HERCULES IN INVESTMENT NEGOTIATIONS WITH EUROPEAN FIRM.
Hercules Development Group (OTC BB: HDVG), Florham Park, N.J., is
currently in negotiations with a European-based pharmaceutical company
for the purposes of strategic investment in Astralis, the . . .
PEDIATRIX EXPECTS TO EXCEED 2001 3RD QTR EPS GUIDANCE.(Pediatrix
Medical Group Inc.)(Brief Article)(Statistical Data Included)
Pediatrix Medical Group, Inc., (NYSE:PDX), Ft. Lauderdale, Fla.,
has announced that it expects to earn 39 to 40 cents per share for the
three months ended September 30, 2001. Pediatrix had . . .
REGENERON SELLS $200M OF CONVERTIBLE SENIOR SUBORDINATE
NOTES.(Regeneron Pharmaceuticals Inc.)(Brief Article)(Statistical Data
I
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Tarrytown, N.J.
has entered into a purchase agreement providing for the sale of $200
million aggregate principal amount of convertible senior . . .
CANTEL REPORTS 20% INCREASE IN INCOME FOR 4TH QUARTER.(Cantel
Medical Corp.)(Brief Article)(Statistical Data Included)
Cantel Medical Corp. (NASDAQ NM:CNTL), Little Falls, N.J., has
reported income from continuing operations of $1,378,000, an increase of
20%, or $0.27 per diluted share, on sales of $14,649,000, an . . .
CHARLES RIVER LABS RAISES 3RD QTR EARNINGS GUIDANCE.(Charles
River Laboratories International Inc., year 2001)(Brief
Article)(St
Charles River Laboratories International, Inc. (NYSE: CRL),
Wilmington, Mass., is raising its previous guidance on estimated
earnings per share performance for the third quarter.
The company . . .
LASERVISION REPORTS 14% INCREASE IN 1ST QTR REVENUES.(Laser
Vision Centers Inc.)(Brief Article)(Statistical Data Included)
Laser Vision Centers, Inc., (Nasdaq:LVCI), St. Louis, has
announced that revenue for the first quarter ended July 31, 2001,
increased 14% to $25,311,000 from $22,237,000 for the same quarter . . .
|
|